A Phase 3 Study of Manganese-primed Immunochemotherapy in Patients With Advanced Ovarian Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 3 Study of Manganese-primed Immunochemotherapy in Patients With Advanced Ovarian Cancer	Adnexal Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder	Recruiting	Phase 3	2026-09-16		NCT07822646

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chinese PLA General Hospital	238

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Bio-therapeutic, First Medical Center, Chinese PLA General Hospital	Beijing	China	1
Department of Gynecologic Oncology, Shanxi Province Cancer Hospital	Taiyuan	China	1
Department of Obstetrics and Gynecology, First Medical Center, Chinese PLA General Hospital	Beijing	China	1
Department of Obstetrics and Gynecology, North China University of Science and Technology Affiliated Hospital	Tangshan	China	1
Department of Obstetrics and Gynecology, Seventh Medical Center, Chinese PLA General Hospital	Beijing	China	1
Peking University International Hospital	Beijing	China	7